MeVis Medical Solutions AG

Total Valuation

MeVis Medical Solutions AG carries a market capitalization of 42.22M, placing it among publicly traded companies globally. Its enterprise value stands at 44.07M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

MeVis Medical Solutions AG currently has 1.82M shares outstanding.

Valuation Ratios

MeVis Medical Solutions AG trades at a trailing price-to-earnings ratio of 5.78. The price-to-sales ratio is 2.58, and the price-to-book ratio stands at 7.34.

Enterprise Valuation

On an enterprise value basis, MeVis Medical Solutions AG trades at an EV/EBITDA multiple of 6.17 and an EV/FCF ratio of 6.53. The EV/Sales ratio of 2.44 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 6.17 provides insight into valuation relative to core operating earnings.

Financial Position

MeVis Medical Solutions AG maintains a current ratio of 2.00, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities.

Financial Efficiency

MeVis Medical Solutions AG posts a return on equity of 126.91 and a return on invested capital of 37.64.

Taxes

Over the trailing twelve months, MeVis Medical Solutions AG has paid 85,000.00 in income taxes, reflecting an effective tax rate of 1.04.

Stock Price Statistics

MeVis Medical Solutions AG's stock has declined approximately -7.93651% over the past 52 weeks. The 50-day moving average sits at 23.05, while the 200-day moving average is 24.57.

Income Statement

Over the trailing twelve months, MeVis Medical Solutions AG generated 18.07M in revenue and converted that into 8.07M in net income, yielding earnings per share of 4.43. EBITDA reached 7.14M, while operating income came in at 7.14M.

Balance Sheet

Total book value stands at 6.36M, with working capital of 3.56M providing operational flexibility.

Cash Flow

MeVis Medical Solutions AG produced 6.54M in operating cash flow over the past twelve months. After subtracting -202,922.14 in capital expenditures, free cash flow totaled 6.34M - equivalent to 3.48 per share.

Margins

MeVis Medical Solutions AG operates with a gross margin of 97.47, reflecting its pricing power and cost economics. The operating margin of 39.51 and net profit margin of 44.66 provide insight into operational efficiency.

Dividends & Yields

Scores

MeVis Medical Solutions AG posts an Altman Z-Score of 6.78, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.